| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
LUNG CANCER |
1 Department of Thoracic and Cardiovascular Surgery, University Hospital, Uppsala, Sweden
2 Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
3 Department of Pulmonary Medicine, Uppsala, Sweden
4 Department of Pulmonary Medicine, Västmanlands County Hospital, Västerås, Sweden
5 Department of Surgery, Västmanlands County Hospital, Västerås, Sweden
Correspondence to:
Correspondence to:
Dr G Myrdal
Department of Thoracic and Cardiovascular Surgery, Uppsala University Hospital, SE-751 85 Uppsala, Sweden; gunnar.myrdal{at}thorax.uas.lul.se
Background: The effect of delay on survival in lung cancer remains uncertain. It is suggested that prompt management of non-small cell lung cancer (NSCLC) can influence prognosis. This study was undertaken to examine the relation between delay and prognosis in patients with NSCLC and to investigate the delay time from first symptom and from first hospital visit to start of treatment.
Methods: Two types of delay (symptom to treatment delay and hospital delay) were investigated in 466 patients treated for NSCLC at two institutions in central Sweden. Delays in relation to clinical characteristics were compared and the effects of delay times and other relevant factors on survival were assessed in multivariate analyses.
Results: Thirty five per cent of patients received treatment within 4 weeks of the first hospital visit and 52% within 6 weeks. Median symptom to treatment delay was 4.6 months and median hospital delay 1.6 months. Older age, advanced tumour stage, and non-surgical treatment were independently related to poor survival. Both prolonged hospital delay and symptom to treatment delay provided additional information when considered separately. In a final multivariate model only increased symptom to treatment delay gave significant information of a better prognosis. There was an association between a short delay and a poor prognosis which was most pronounced in patients with advanced disease.
Conclusion: When considering the whole study population and all stages of tumour together, shorter delay was associated with a poorer prognosis. This is likely to reflect the fact that patients with severe signs and symptoms receive prompt treatment. These findings indicate that the waiting time for treatment in patients with NSCLC is longer than recommended.
Keywords: lung cancer; treatment delay; hospital delay
This article has been cited by other articles:
|
|
 |
|
  M. P. Devbhandari, P. Quennell, P. Krysiak, R. Shah, and M. T. Jones Implications of a negative bronchoscopy on waiting times to treatment for lung cancer patients: results of a prospective tracking study Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 479 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Shugarman, M. E.S. Sorbero, H. Tian, A. K. Jain, and J. S. Ashwood An Exploration of Urban and Rural Differences in Lung Cancer Survival Among Medicare Beneficiaries Am J Public Health, July 1, 2008; 98(7): 1280 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Gould, S. J. Ghaus, J. K. Olsson, and E. M. Schultz Timeliness of Care in Veterans With Non-small Cell Lung Cancer Chest, May 1, 2008; 133(5): 1167 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, F. Liu, H. Gao, W. Wei, X. Zhang, Y. Liang, and Y. Cheng The Symptom-to-Treatment Delay and Stage at the Time of Treatment in Cancer of Esophagus Jpn. J. Clin. Oncol., February 5, 2008; (2008) hym169v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Spiro, M. K. Gould, and G. L. Colice Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 149S - 160S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Loh, L. Chan, R. Tan, S. Govindaraju, K. Ratnavelu, S. Kumar, S. Raman, P. Vijayasingham, and T. Thayaparan Effect of time delay on survival in patients with non-small cell lung cancer A Malaysian study Asia Pac J Public Health, March 1, 2006; 18(1): 69 - 71. [PDF]
|
|
|
|
|
|
E.-R. Salomaa, S. Sallinen, H. Hiekkanen, and K. Liippo Delays in the Diagnosis and Treatment of Lung Cancer Chest, October 1, 2005; 128(4): 2282 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S S Birring and M D Peake Symptoms and the early diagnosis of lung cancer Thorax, April 1, 2005; 60(4): 268 - 269. [Full Text] [PDF]
|
|
|
|
|
|
J Corner, J Hopkinson, D Fitzsimmons, S Barclay, and M Muers Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis Thorax, April 1, 2005; 60(4): 314 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Moody, M Muers, and D Forman Delays in managing lung cancer Thorax, January 1, 2004; 59(1): 1 - 3. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
